|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 3209685 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15853465.1 |
| Date of filing the European patent application | 2015-10-23 | |
| (97) | Date of publication of the European application | 2017-08-30 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation | 2019-08-26 |
| (86) | Number | PCT/US2015/057223 |
| Date | 2015-10-23 |
| (87) | Number | WO 2016/065323 |
| Date | 2016-04-28 |
| (30) | Number | Date | Country code |
| 201462067908 P | 2014-10-23 | US | |
| 201562148656 P | 2015-04-16 | US | |
| 201562188353 P | 2015-07-02 | US | |
| 201562210795 P | 2015-08-27 | US |
| (72) |
SINGH, Sunanda, US
|
| (73) |
Singh Molecular Medicine, LLC,
14153 Yosemite Drive, Suite 101, Hudson, FL 34667,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai su vienu duomenu, nukreipti prieš viduląstelinius antigenus |
| SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS |
| Payment date | Validity (years) | Amount | |
| 2022-10-03 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-10-23 |